CN Patent

CN101965409A — 具有增加的稳定性的重组因子viii

Assigned to University of Rochester · Expires 2011-02-02 · 15y expired

What this patent protects

本发明涉及重组因子VIII，所述重组因子VIII包括导致因子VIII和因子VIIIa两者的稳定性增强的一种或多种突变。还公开了制备和使用所述重组因子VIII的方法和含有所述重组因子的药物组合物。本发明还涉及编码所述重组因子VIII的分离的核酸分子以及含有所述分离的核酸分子的DNA表达系统和宿主细胞。

USPTO Abstract

本发明涉及重组因子VIII，所述重组因子VIII包括导致因子VIII和因子VIIIa两者的稳定性增强的一种或多种突变。还公开了制备和使用所述重组因子VIII的方法和含有所述重组因子的药物组合物。本发明还涉及编码所述重组因子VIII的分离的核酸分子以及含有所述分离的核酸分子的DNA表达系统和宿主细胞。

Drugs covered by this patent

Patent Metadata

Patent number
CN101965409A
Jurisdiction
CN
Classification
—
Expires
2011-02-02
Drug substance claim
No
Drug product claim
No
Assignee
University of Rochester
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.